Yunfei Yi

860 total citations
17 papers, 721 citations indexed

About

Yunfei Yi is a scholar working on Biomedical Engineering, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yunfei Yi has authored 17 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Biomedical Engineering, 8 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yunfei Yi's work include Nanoplatforms for cancer theranostics (15 papers), RNA Interference and Gene Delivery (5 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Yunfei Yi is often cited by papers focused on Nanoplatforms for cancer theranostics (15 papers), RNA Interference and Gene Delivery (5 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Yunfei Yi collaborates with scholars based in China, United States and Canada. Yunfei Yi's co-authors include Mian Yu, Lin Mei, Meiying Wu, Meitong Ou, Chenyi Huang, Weiwei Zeng, Dunwan Zhu, Yuanqi Liu, Tianqi Wang and Shengjie Sun and has published in prestigious journals such as Biomaterials, Chemical Engineering Journal and Journal of Controlled Release.

In The Last Decade

Yunfei Yi

16 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yunfei Yi China	11	504	256	227	144	141	17	721
Yikai Xu China	14	527 1.0×	269 1.1×	263 1.2×	161 1.1×	134 1.0×	24	804
Yesi Shi China	14	539 1.1×	383 1.5×	225 1.0×	217 1.5×	129 0.9×	23	958
Jia Tan China	15	518 1.0×	342 1.3×	292 1.3×	125 0.9×	194 1.4×	33	902
Qinghao Zhou China	15	519 1.0×	199 0.8×	241 1.1×	293 2.0×	121 0.9×	27	762
Yaqian Du China	15	584 1.2×	311 1.2×	403 1.8×	104 0.7×	79 0.6×	30	903
Zhaoqing Shi China	13	518 1.0×	233 0.9×	243 1.1×	270 1.9×	135 1.0×	16	802
Mengbin Ding China	16	524 1.0×	158 0.6×	172 0.8×	180 1.3×	126 0.9×	31	670
Lingpu Zhang China	11	339 0.7×	237 0.9×	171 0.8×	176 1.2×	100 0.7×	15	615
Yong‐Guo Hu China	12	635 1.3×	197 0.8×	226 1.0×	236 1.6×	44 0.3×	24	810
Shu‐Cheng Wan China	14	469 0.9×	327 1.3×	383 1.7×	83 0.6×	186 1.3×	23	913

Countries citing papers authored by Yunfei Yi

Since Specialization

Citations

This map shows the geographic impact of Yunfei Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunfei Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunfei Yi more than expected).

Fields of papers citing papers by Yunfei Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunfei Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunfei Yi. The network helps show where Yunfei Yi may publish in the future.

Co-authorship network of co-authors of Yunfei Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Yunfei Yi. A scholar is included among the top collaborators of Yunfei Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunfei Yi. Yunfei Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Yi, Yunfei, Yuanqi Liu, Huisong Hao, et al.. (2025). siRNA micelleplexes-mediated glutamine metabolism re-engineering for vascular normalization-boosted photo-immunotherapy. Acta Pharmaceutica Sinica B. 15(4). 2237–2252. 2 indexed citations

Hao, Huisong, Yunfei Yi, Shengjie Sun, et al.. (2025). Exploiting eNOS activation to achieve tumor vascular normalization via endothelial transcytosis of lipid nanoparticles. Acta Pharmaceutica Sinica B. 16(3). 1717–1732.

Hao, Huisong, Shengjie Sun, Simin Wen, et al.. (2024). Magnesium peroxide-based biomimetic nanoigniter degrades extracellular matrix to awake T cell-mediated cancer immunotherapy. Biomaterials. 317. 123043–123043. 1 indexed citations

Yi, Yunfei, Yichu Nie, Jia Tang, et al.. (2024). Softening the tumor matrix through cholesterol depletion breaks the physical barrier for enhanced antitumor therapy. Journal of Controlled Release. 371. 29–42. 9 indexed citations

Yi, Yunfei, Mian Yu, Wen Li, et al.. (2023). Vaccine-like nanomedicine for cancer immunotherapy. Journal of Controlled Release. 355. 760–778. 97 indexed citations

Liu, Yuanqi, Yunfei Yi, Shengjie Sun, et al.. (2023). Biodegradable and Efficient Charge‐Migrated Z‐Scheme Heterojunction Amplifies Cancer Ferroptosis by Blocking Defensive Redox System. Small. 20(23). e2309206–e2309206. 5 indexed citations

Yi, Yunfei, Chan Feng, Mian Yu, et al.. (2023). Peptide-based siRNA delivery system for tumor vascular normalization and gene silencing in 4T1 cells. STAR Protocols. 4(1). 102138–102138. 3 indexed citations

Lin, Chuchu, Chenyi Huang, Zhaoqing Shi, et al.. (2022). Biodegradable calcium sulfide-based nanomodulators for H2S-boosted Ca2+-involved synergistic cascade cancer therapy. Acta Pharmaceutica Sinica B. 12(12). 4472–4485. 45 indexed citations

Yu, Mian, Weiwei Zeng, Yunfei Yi, et al.. (2022). ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy. Biomaterials. 284. 121503–121503. 55 indexed citations

10.

Wang, Yang, Yunfei Yi, Haoqiang Wan, et al.. (2022). Isoginkgetin synergizes with doxorubicin for robust co-delivery to induce autophagic cell death in hepatocellular carcinoma. Acta Biomaterialia. 153. 518–528. 12 indexed citations

11.

Yu, Mian, Yunfei Yi, Ting Chen, et al.. (2022). Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy. Journal of Controlled Release. 347. 104–114. 60 indexed citations

12.

Hao, Huisong, Mian Yu, Yunfei Yi, et al.. (2022). Mesoporous calcium peroxide-ignited NO generation for amplifying photothermal immunotherapy of breast cancer. Chemical Engineering Journal. 437. 135371–135371. 41 indexed citations

13.

Yi, Yunfei, Mian Yu, Chan Feng, et al.. (2022). Transforming “cold” tumors into “hot” ones via tumor-microenvironment-responsive siRNA micelleplexes for enhanced immunotherapy. Matter. 5(7). 2285–2305. 95 indexed citations

14.

Wang, Tianqi, Shengjie Sun, Chenyi Huang, et al.. (2022). Exosome-based drug delivery systems in cancer therapy. Chinese Chemical Letters. 34(2). 107508–107508. 32 indexed citations

15.

Zeng, Weiwei, Mian Yu, Ting Chen, et al.. (2022). Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy. Advanced Science. 9(23). e2201703–e2201703. 134 indexed citations

16.

Zhou, Yun, Mian Yu, Changjun Tie, et al.. (2021). Tumor Microenvironment-Specific Chemical Internalization for Enhanced Gene Therapy of Metastatic Breast Cancer. Research. 2021. 9760398–9760398. 27 indexed citations

17.

Hu, Hang, Jitang Chen, Hai Yang, et al.. (2019). Potentiating photodynamic therapy of ICG-loaded nanoparticles by depleting GSH with PEITC. Nanoscale. 11(13). 6384–6393. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact